Descovy (emtricitabine/tenofovir alafenamide) is a brand-name prescription drug that’s used to help prevent HIV. It’s not available as a generic drug. Descovy comes as an oral tablet.

Tenofovir alafenamide fumarate is used in multiple combination pills for HIV. Doctors do not recommend it as a stand-alone treatment. Other NRTIs (emtricitabine, lamivudine, and tenofovir ...

At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV ...

Switching from a boosted protease inhibitor (bPI)–based regimen to bictegravir plus emtricitabine plus tenofovir alafenamide (B/F/TAF) maintained virological suppression over 48 weeks in ...

HIV, or Human Immunodeficiency Virus, is a type of virus that weakens the immune system, making one susceptible to a variety of infections. Although there is no cure for HIV, with the right treatment, ...

The US PrEP market is dominated by Truvada (plus generic versions of the drug in some markets), as well as Gilead's follow-up Descovy (emtricitabine and tenofovir alafenamide), a once-daily oral ...

tenofovir alafenamide and emtricitabine (TAF/FTC). As no studies have previously tested TAF/FTC in cisgender women, drug regulators have not approved the formulation for this population. The ...

tenofovir alafenamide fumarate. Tigar said the drug company didn't cite an appropriate authority to show how a plaintiff cannot withstand summary judgment on a defective design claim when presenting ...

SAN FRANCISCO -- Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir ...

Further information Decision makers agreed that a Technology Appraisal (TA) would not be appropriate for the subject technology due to the commissioning arrangements ...